神州泰嶽(300002.SZ):擬與眾創資本共同出資設立合夥企業
格隆匯5月30日丨神州泰嶽(300002.SZ)公佈,為積極發掘具有良好成長性和發展前景的戰略性新興項目,進一步促進公司整體戰略目標的實現。公司擬與前海眾創資本管理(深圳)有限公司(“眾創資本”)共同出資設立蘇州眾創匯智創業投資合夥企業(有限合夥)(最終以經工商登記管理機關核准的名稱為準,“合夥企業”),該合夥企業的認繳出資總額為人民幣7500萬元,其中,公司出資7425萬元,持有其99%的權益份額,為合夥企業的有限合夥人;眾創資本出資75萬元,持有其1%的權益份額,為合夥企業的普通合夥人。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.